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Objectives: Medicines reconciliation is an effective way of reducing errors at transitions of 
care. Much of the focus has been on medicines reconciliation at point of admission to 
hospital. Our objective was to evaluate medicines reconciliation after discharge from hospital 
by assessing the quality of information regarding medicines within discharge summaries and 
determining whether the information provided regarding medicines changes were acted 
upon within 7 days of receiving the discharge information. 
 
Methods: A retrospective collaborative evaluation of medicines related discharge 
information by Clinical Commissioning Group (CCG) pharmacists using standardised data 
collection tools.  Outcomes of interest included compliance with national minimum standards 
for medication related information on discharge summaries, such as allergies, changes to 
medication regimen, minimum prescription standards e.g. dose, route, formulation and 
duration, and medicines reconciliation by the primary care team.  Data was analysed centrally. 
 
Results: 43 CCGs covering each of the four NHS Regions in England participated in the study 
and submitted data for 1454 patients and 10,038 prescribed medicines. The majority of 
medication details were stated in accordance with standards with the exception of indication 
(11.7% compliance), formulation (60.3% compliance) and instructions of on-going use (72.5% 
compliance). Documentation about changes was poor: 1550/3164 (49%) newly started 
medicines, 186/477 (39%) dose changes, and 420/738 (57%) stopped medicines had a reason 
documented. Changes were not acted upon within 7 days of receiving the discharge 
information for 12.5% of patients. 
 
Conclusions: Our evaluation revealed overall good compliance with discharge medication 
documentation standards, but a number of changes to medicines during hospitalisation were 
not fully communicated or documented on the discharge summary or actioned in the General 
Practice after discharge.  
 
Key Messages 
What is already known on this subject 
 Medicines Reconciliation rates on admission to hospital  is a key performance indicator 
for the majority of NHS trusts in England 
 Poor communication of medicines related issues during transfer of care is a patient safety 
concern 
 Evidence form primary care studies demonstrate that General Practitioners have concerns 
around the quality of information provided by secondary care around medication changes 
What this study adds 
 First England-wide evaluation of the quality of discharge information about medicines 
 There continues to be poor communication to GPs particularly around documented 
reasons for changes to medication  





Medicines reconciliation is recognised globally as a process that supports patient safety 
however the majority of the focus in developed health systems has been targeted on 
implementing medicines reconciliation at admission to hospital [1,2,3,4]. Few studies have 
researched the practice at the point of discharge from secondary care (hospital care) into 
primary care (care provided whilst at home) despite a substantial body of evidence 
demonstrating that when patients move between care providers/interfaces (particularly from 
secondary care to primary care) the risk of miscommunication around changes to medicines 
is a significant problem [5,6,7,8,9,10].  
 
The focus of this paper is medicines reconciliation practices during the discharge of patients 
from secondary care to primary care in the United Kingdom (UK) setting. In the UK, a 2009 
report [11] by the health and social care regulator, the Care Quality Commission (CQC), stated 
that acute NHS trusts (hospitals) need to improve the information they provide on changes 
to medication at discharge and made the following recommendation: “Ensure that contracts 
with acute trusts set out the requirements and quality markers for both the timeliness and 
content of discharge summaries. Information on diagnosis, changes to medication and the 
reason for them must be included. They should put in place contract variations to set this in 
place at the earliest opportunity, including incentives through the commissioning for higher 
quality and innovation (CQUIN) system and penalties for poor contract performance”. Prior to 
the CQC concerns, several national organisations and Royal Colleges [12, 13] had developed 
standards focussing on what (and how) medicines related information should be 
communicated on the discharge summary/prescription when patients are transferred from 
secondary care to primary care. Following the CQC concerns in 2011, the UK Department of 
Health developed a toolkit to support NHS organisations to improve communication of 
medicines related information during transfer of care [14].  Despite these efforts before and 
after the CQC concerns, evidence suggests that communication of medicines related 
information at discharge from hospital remains problematic [6,15,16]. The landmark Practice 
study [5] discussed some of the difficulties that General Practitioners (GPs) face when dealing 
with hospital discharge medications. For example, GPs highlighted the need for the wording 
of hospital correspondence to be clear and accurate with any medication changes clearly 
highlighted. 
 
The objectives of this collaborative service evaluation led by the National Medicine Use and 
Safety Team (MUS) of the NHS England Specialist Pharmacy Service [17] were to: 
(1) Assess the quality of information regarding medicines within discharge summaries 
provided by secondary care (Acute, Mental Health and Community Services)  
(2) Determine whether GPs correctly acted upon the information provided regarding 
medicines in the discharge summaries within 7 days of receiving the discharge information as 






The study was designed as an audit and retrospective review of discharge information by 
Clinical Commissioning Group (CCG) Pharmacists using data collection guidance notes and 
tools developed by a steering group. The steering group comprised of relevant stakeholders 
including pharmacists from primary care, secondary care and academia as well as a NICE 
medicines implementation consultant.  CCGs are clinically-led statutory NHS bodies 
responsible for the planning and commissioning of health care services for their local area. 
CCG pharmacists act as prescribing advisers and have knowledge of and access to GP systems 
and records.  
 
In December 2015 all Heads of Medicines Management/Chief Pharmacists in CCGs and 
Commissioning Support Units (organisations that provide services to CCGs that allows them 
to focus their clinical commissioning) across England were invited to participate in the study. 
Upon expression of interest each CCG/CSU lead was emailed the necessary study tools 
(Protocol, Data Collection Form, Hints and Tips Document and a collation of Frequently Asked 
Questions)[17], which had been piloted. During January 2016 the CCG pharmacists identified a 
list of patients in GP practices who had been discharged on medication from secondary care 
in the period October to December 2015.  Using consecutive sampling methodology, every 
2nd patient on the list was selected until the required sample size of a minimum of 1 patient 
per 50,000 population per CCG was reached.  
 
Outcomes of interest included compliance with national minimum standards [10,13] for 
medication related information on discharge summaries, such as allergies, changes to 
medication regimen as well as minimum prescription standards i.e. dose, route, formulation 
and duration.  An area of high priority within the audit was to ascertain the quality of allergy 
status recording on discharge summaries/prescriptions. The standard set followed the 
recommendations made in the NICE CG 183 on Drug allergy: diagnosis and management [18]. 
The methodology required the CCG pharmacist to compare the allergy status on the GP 
system with the allergy documentation on the discharge summary/prescription and interpret 
whether the allergy status on the latter reflected those details kept in the GP electronic 
systems whilst being mindful that the patient may have developed new allergies during 
hospitalisation.  Secondly, the CCG pharmacists were requested to reconcile medicines 
between the discharge summary and the pre-admission medication list on the GP system and 
record any unintended discrepancies that they identified.  Finally, they were also asked to 
document whether the GP had implemented any recommendations or changes from 
secondary care and any errors with potential for harm, and to attempt to identify which 
member of the GP practice team undertook the medicines reconciliation.  
 
Other information such as patient age and gender, route of admission to hospital (planned or 
unplanned), length of hospital stay, format of discharge prescription, whether or not there 
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was evidence of a pharmacist review or sign off (clinical screening) for the discharge summary, 
and length of time before the GP received the discharge summary was also collected. 
  
An excel spread sheet was provided to aid data collection and submission by CCG pharmacists 
to the MUS team. Full details of methods and data collection tools are available on the NHS 
England Specialist Pharmacy Service website [17].   MUS team collated all the datasets received 
and analysed the results centrally. Compliance to discharge summary documentation was 
calculated using the number of discharge summaries where the requisite information was 
present divided by the total number of discharge summaries expressed as a percentage. 
Compliance to medicine prescription standards was calculated using the number of medicines 
with the requisite information stated divided by the total number of medicines prescribed. 
Missing and ambiguous data was excluded from analysis and reported as appropriate. The 
sample size (n) stated throughout the results section reflects either the number of patient 
discharge summaries reviewed or the number of medicines prescribed. The data was 
analysed and formulated into a national report and presented to all the Regional Chief 
Pharmacist Groups in England. Each participating CCG was provided with a short report 
benchmarking their results against the national dataset.  
 
As this was a service evaluation, NHS Research Ethics approval was not required.  
 
Results  
 Forty three CCGs covering each of the four NHS Regions in England participated in the study 
representing approximately 20% of the CCGs in existence at the time. A total of 1454 patient 
discharge summaries and 10,038 prescribed medicines (mean of 6.9 medicines per patient) 
from 74 hospitals were reviewed. The median number of patients reviewed per CCG was 10 
with a range of three to 404, with a significant (47%) proportion of the data returns from 
three CCGs only. 
 
The median length of inpatient stay was four days, although two patients had a stay of over 
100 days and one patient exceeded 200 days. The majority (78.6%) of patients audited were 
unplanned admissions.  Generally communication of the inpatient stay to the GP was timely 
with the arrival of the discharge summary on the same day as the discharge - however there 
were some outliers with one discharge summary taking 38 days to arrive. Table 1 below shows 
the key demographic and pertinent indicators of the study sample. 
 
 Table 1: Key Demographic and pertinent indicators of the study sample 
 Indicator Value/ Result 
Total number of patient discharge summaries audited 1,454 





Total number of participating CCGs∞  43 
Total number of hospitals  74 
Median age of patients audited (n=1419) 72 years (range 0 – 102 
years) 
Gender of patients audited (n=1433) Female = 53% 
Male = 47% 
Median length of inpatient stay (n= 1454) 4 days (range 0 – 208 days) 
Median length of time before GPµ received the  discharge 
summary/prescription  (n=1434) 
Same day as discharge 
(range 0 – 38 days) 
Route of admission (n=1454) Unplanned – 78.6% 
Planned – 21.4% 
Format of discharge summaries (n=1454) Electronic – 89% 
Handwritten – 11% 
 ∞ CCG = Clinical Commissioning Group  
 µGP – General Practitioner    
 
Communication of Changes to Medication  
1146 patients (79%) of the study sample had at least one new medicine started whilst an 
inpatient, 169 patients (11.6%) had five or more new medicines started and one patient had 
13 new medicines started.  Of the 3164 new medicines started across the study sample, only 
49% had a reason documented on the discharge summary for why the medicine was being 
commenced.   
 
Doses were changed of at least one medicine for 336 patients (23%) of the study sample 
during their inpatient stay.  25 patients (1.72%) had three or more of their doses changed and 
one patient had the doses of 10 medicines changed during their inpatient admission. Of the 
477 medicines that were subjected to dose changes, only 39% had reason documented for 
the change.  
 
At least one medicine was stopped in hospital for 388 patients (27%) of the study sample.  84 
patients (5.7%) had three or more medicines stopped and one patient had 10 medicines 
stopped during their inpatient admission. Of the 738 medicines stopped across the study 
sample, only 57% had a reason documented for why the medicine was being stopped.  Aside 
from them 738 medicines that were definitively stopped, the evaluation also identified 1565 
pre-admission medicines (mean of 1.1 medicine omission per discharge 
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summary/prescription) that appeared to be inappropriately omitted from the discharge 
summary/prescription and presumably omitted for the duration of the inpatient stay. 
 
Table 2 summarises the results regarding the communication and actions taken for 
medication changes. 
Table 2: Medication changes and communication at discharge for medicines that have been 








Number of patients who 
had at least one 
medication change*  
1146  336  388  479 
Total number of 
medicines started, dose 
changed, stopped or 
unintentionally omitted 
3164 477 738 1565 
Number of medicines 
that had a reason 
documented for the 
medication change 
562 (49%) 186 (39%) 420 (57%) 0 
Percentage of patients 
who had their medication 




















Percentage of patients 
who had their medication 
changes intentionally 





















Percentage of patients 
who had their medication 
changes actioned 





















*numbers exceed 1454 as patients may have had more than one medication change 
 
Processing of actions by primary care as required by the hospital discharge summary 
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For patients with a change in medication (started, stopped or doses changed) during the 
inpatient stay, in approximately 45% of cases the GP practice did action these changes within 
7 days of receiving the discharge summary. In 42% of cases although medication changes took 
place during the inpatient stay there was no need for the GP to change anything on their 
prescribing system e.g. short courses of medicines.  For the remaining 12.5% of patients the 
changes were not acted upon by the GP within 7 days of receiving the discharge summary.  
 
In approximately half of the patients audited the GP was clearly involved in reconciling the 
patient’s medication following discharge from hospital. In the remainder of the patients other 
team members from within the GP surgery were identified as being the primary individual 
involved in reconciling the patient’s medication (table 3). 
 
Table 3: Medication reconciliation in primary care: 
 
 National Audit Results 
For medicines that were Started/Stopped or 
Doses Changed during the hospital inpatient 
stay, were the changes actioned by the GP 
within 7 days of the discharge being received? 
(n=1438) 
Yes = 655 (45.5%)  
No = 180 (12.5%)  
No action required = 603 (42%) 
Who carried out the medicines reconciliation 
within the GP surgery for the discharge 
summaries received? (n=1441) 
 
 
GP = 742 (51.5%) 
No requirement to undertake Medicines 
Reconciliation = 217 (15.1%) 
Unable to identify = 101 (7%) 
CCG/Practice Pharmacist = 95 (6.6%) 
Medicines Reconciliation not 
undertaken = 82 (5.7%) 
Practice Receptionist = 80 (5.6%) 
Practice Nurse = 7 (0.49%) 
Practice Manager = 1 (0.07%) 







Meeting the prescribing standards   
There was high compliance with many of the prescribing standards (figure 1), but information 
about allergies, indication, formulation of the drug and instructions for ongoing use was not 
always documented. 
 
Figure 1: Discharge summary demographic and information data compliance   
 
* Medicines were considered to be written appropriately if written by generic name unless 
branded prescribing was warranted for example due to bioavailability issues or inhaler 
preparations where brand specificity is important 
 
Pharmacist clinical screening of the discharge summary  
In approximately half (49%) of the discharge summaries audited there was clear evidence that 
they had been clinically reviewed (screened) by the secondary care pharmacist prior to being 
sent to the GP. 88% of discharge summaries that had been screened included the 
pharmacist’s name, but only 4% stated the contact details of the screening pharmacist.  
 
Resolution of unintentional discrepancies  
Although the study was not designed to measure the resolution of the unintentional 
discrepancies identified as part of the data collection, the CCG Pharmacists qualitatively 
reported a number of follow up actions that they undertook (see box 1). The key actions taken 
were contacting the secondary care prescriber or pharmacist, contacting the GP to ensure 
discrepancies were reviewed or contacting the patient and or carer to establish their 
medication use. 
 
Box 1 – Verbatim comments from CCG Pharmacists regarding follow up actions for 
unintentional discrepancies  
 
“GP to clarify new drugs which were not added to current PAMβ” 
“Had to contact carer to re-iterate if atorvastatin had been stopped by hosp[ital] 
as not listed on TTA≥” 
“At the time of discharge the dose of azithromycin had to be clarified with the Dr 
as the wrong dose (1 om[in the morning]) was on the discharge instead of the 
usual PAM* of 1 3x wkly [three times a week].” 
“Checked with patient if they have enough supply for newly started anticoagulant 
drug until further sec[ondary] care clinic” 
“GP to follow up dose that was not changed” 
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“GP - Dose of mouthwash altered from formulary default to that recommended by 
specialist unit 
 “Potential for significant incident – SIRMS$ report filed” 
“Illegible - had to phone eye clinic to check” 
“GP to clarify new drugs which were not added to current medication list” 
 
 
β – Pre admission medication list  
≥ - To Take Away Prescription 





The results of this national evaluation demonstrate that the communication of medicines 
related information on the discharge summary/prescription from secondary care to primary 
care is problematic and requires improvement. 
 
Firstly, lower than expected compliance for minimum prescribing standards were surprising 
as these standards [12, 13]  have been available since 2012. In theory, organisations had the 
opportunity to develop discharge templates to meet the national standards (particularly 
where electronic). The low rate for documenting the indication may reflect the challenges of 
hospital staff not always knowing the primary indication for established or chronic medicines, 
particularly if it has no bearing on the patient’s admission. Recording an erroneous or 
assumed indication in the absence of certainty has the potential to lead to confusion for the 
patient and GP. 
 
Secondly, there was omission of established medicines throughout hospitalisation, at a mean 
rate of 1.1 medicines omitted per discharge summary.    This suggests inadequate or a 
complete lack of medicines reconciliation being undertaken on admission to hospital and is 
comparable to another UK study of the quality of medicines reconciliation on hospital 
admission, which reported 0.97 omitted medicines [19]. 
 
Thirdly, only half of the discharge summaries had evidence of a clinical pharmacist review or 
screening.  However, it cannot be assumed that the remaining half were not clinically 
screened by the pharmacist; potential reasons for absence of evidence include the design of 
the discharge summary template, which may not have included pharmacist screening details.  
For this reason, sub-analysis to compare the influence of pharmacist screening was not 
performed. 
 
Finally, reasons for changes to medication were only documented in approximately half the 
instances. Failure of secondary care prescribers to document details and rationale for 
medication changes, including initiation, on the discharge summary may be explained in part 
by the fact that a proportion of the prescribed medicines were for short courses or self-
limiting conditions. For example, indications or durations of prescriptions for painkillers, 
laxatives, short antibiotic courses may be considered evident and the GP would not have been 
expected to continue these prescriptions.  
 
Our findings are similar to two other UK studies with similar aims. Hammad et al reported low 
compliance for the quality of medicines related information contained within 3444 discharge 
summaries compared to the standards set out by UK National Prescribing Centre [15]. Of note, 
only 48.9% of discharge summaries complied with standards around the communication of 
medication therapy changes (medicines initiated, discontinued or doses changed with a 
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corresponding reason).  Similarly, Grimes et al, in a study of 1245 discharge summaries 
reported that medication details documented at discharge from acute hospital care 
frequently contained prescription writing errors or failed to communicate information 
regarding changes to medication made whilst an inpatient[6].  In their study, 21.5% of 
discharges failed to document that a medicine that the patient had been taking prior to 
admission had been stopped during the inpatient stay.[6]   
 
A positive finding was that 89% of the discharge summaries were electronic and reached the 
GP on the same day.  Despite this, for 12.5% of patients with medication changes that 
required action, this did not happen within 7 days of receiving the discharge summary.  It is 
probable that appropriate actions were taken outside of the 7 day window.  Once the 
discharge summary was received various members of the primary care team were reported 
to have processed the medication related actions. Both these findings require further study, 
as we did not analyse or explore the potential clinical consequences of delay in actioning the 
changes or ramifications of individuals other than the GP acting on the information contained 
in the discharge summary.  
 
Although the study was not designed to identify any patient safety issues as part of the data 
collection, some of the CCG Pharmacists undertaking the data collection reported 
interventions they undertook to ensure that the patient’s medication regime was safe and as 
intended post hospitalisation. These included correcting erroneous actions regarding the 
medication changes post hospitalisation and contacting the secondary care prescriber or 
pharmacist for clarity or confirmation of changes. This unexpected qualitative feedback 
highlights the need for clear and accurate discharge prescriptions, including contact details of 
secondary care staff. 
 
Strengths and limitations 
This is one of the largest studies undertaken in the UK encompassing 43 CCGs and 74 
hospitals, however there are limitations that need to be considered when interpreting the 
results.  Many people were involved in data collection, which can introduce variability.  This 
was recognised and minimised by developing a standard data collection tool that had drop 
down menus and prompts, providing a hints and tips document, and a clear data collection 
methodology.  Nearly half of the data came from three CCGs and this may limit the 
generalisability of the findings. Even though patient safety issue were reported, the study was 
not designed to assess patient outcomes. 
  
Practice and policy Implications 
The study highlights and focusses on a significant medication safety issue in the context of a 
national picture and at individual hospital and CCG level. The results have been presented to 
Chief Pharmacist groups across England and the following recommendations were made to 




 CCGs and secondary care providers should collaborate to review the local hospital 
discharge template to ensure that it meets the needs of all involved, is in line with the 
standards set by the Royal Pharmaceutical Society[10] and the Academy of Royal 
Colleges[13] and supports transfer of medication related information 
 CCGs to consider developing CQUINs to drive improving the quality of discharge 
communication by secondary care as previously recommended by the CQC. 
 Secondary care providers and hospital pharmacists should ensure that the medicines 
reconciliation process at admission is robust as this will affect the quality of medicines 
related information contained in the discharge summary. 
 Shared access to records that allow health and medicines related information to be kept 
up to date for example using the summary care record  
 GP practices should have clear processes in place on how information provided on 
discharge summaries/prescriptions is managed once received.  
 Consideration should be given to designating the responsibility of reconciling medicines 
post hospitalisation to the growing number of clinical pharmacists employed within GP 
practices. 
 
The authors are aware that post publication of the report in mid-2016 some CCGs have 
developed CQUINS (quality targets) to improve some of the issues identified in this study. The 
Northern Ireland Regulation and Quality Improvement Authority[20] also sought permission to 
utilise and/or modify the tools within this study to conduct their regional audit of medicines 
reconciliation on discharge documentation. 
 
Conclusions  
Despite overall good compliance with standards of documentation for discharge summaries, 
our evaluation revealed issues with medicines reconciliation at transfers for care into and 
from hospital, with a number of changes to medicines during hospitalisation that were not 
fully communicated or documented on the discharge summary or actioned in the General 
Practice after discharge. 
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What this paper adds 
 First England-wide evaluation of the quality of discharge information about medicines 
 There continues to be poor communication to GPs particularly around documented 
reasons for changes to medication  
 Some changes are documented incorrectly on the GP systems 
 Until there is a fully integrated health care record - there are opportunities for electronic 
prescribing in secondary care to improve the situation  
 There is a potentially significant role for the new workforce of clinical Pharmacist in GP 
practices to improve the quality of medicines reconciliation in primary care for patients 
discharged from hospital.   
 
References  
1. National Patient Safety Agency (2007) NICE/ NPSA. Guidance to Improve Medicines 





2. The Joint Commission (2015) National Patient Safety. National Patient Safety Goals 
Effective Accreditation Programme. Accessed in March 2018 via 
https://www.jointcommission.org/assets/1/6/2015_NPSG_HAP.pdf 
3. World Health Organisation’s High 5s Medicines Reconciliation Project. 
http://www.safetyandquality.gov.au/our-work/medication-safety/medication-
reconciliation/who-high-5s-medication-reconciliation-program/  
4. National Institute for Health and Clinical Excellence (NICE). Medicines optimisation: the 
safe and effective use of  medicines to enable the best possible outcomes. March 2015. 
Accessed in March 2018 via https://www.nice.org.uk/guidance/ng5   
5. Avery T, Barber N, Ghaleb M et al. Investigating the prevalence and causes of prescribing 
errors in general practice: The PRACtICe Study.  Nottingham: General Medical Council 
2011. 
6. Grimes TC, Duggan CA, Delaney TP et al. Medication details documented on hospital 
discharge: cross sectional observational study of factors associated with medication non-
reconciliation. British Journal of Clinical Pharmacology 2011; 71 (3): 449-457. 
7. Barber ND, Aldred, DP, Raynor DK et al. Care homes’ use of medicines study: prevalence, 
causes and potential harm of medication errors in care homes for older people.  Quality 
and Safety of Healthcare 2009; 18: 341-346.  
8. Collins DJ, Nickless GD, Green CF. Medication histories; does anyone know what medicines 
a patient should be taking? Int J Pharmacy Practice 2004; 12: 173-178. 
9. Hippisley-Cox JH, Pringle M, Cater R et al. The electronic patient record in primary care- 
regression or progression? A cross sectional study. Br Med J 2003; 236: 1439-1443. 
10. Royal Pharmaceutical Society. Keeping patients safe when they transfer between care 
providers –getting the medicines right. Final Report 2012. Accessed in March 2018 via 
https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Pub
lications/Keeping%20patients%20safe%20transfer%20of%20care%20report.pdf 
11. Care Quality Commission (CQC). Managing patients’ medicines after discharge from 
hospital. 2009. Accessed in April 2018 via 
http://webarchive.nationalarchives.gov.uk/20101122140156/http://www.cqc.org.uk/_d
b/_documents/Managing_patients_medicines_after_discharge_from_hospital.pdf 
12. National Prescribing Centre. Medicines reconciliation: a guide to implementation. 2008. 
Accessed in April 2018 via 
https://www.nicpld.org/courses/fp/assets/MM/NPCMedicinesRecGuideImplementation
.pdf 
13. Academy of Medical Royal Colleges. A Clinician’s Guide to Record Standards – Part 1: 
Why standardise the structure and content of medical records? 2008. Accessed in April 
2018 via https://www.rcoa.ac.uk/sites/default/files/FPM-clinicians-guide1.pdf 
14. Department of Health .The discharge Summary Tool Kit, Department of Health, 2011 
15. Hammad E, Wright D, Walton C et al. Adherence to UK national guidance for discharge 




16. Dodds L. Improving safe and accurate transfer of medicines-related written discharge 
information: a pharmacy-led collaborative audit and service evaluation. 2012. Accessed 
on April 2018 via https://www.sps.nhs.uk/articles/improving-safe-and-accurate-
transfer-of-medicines-related-written-discharge-information-a-pharmacy-led-
collaborative-audit-and-service-evaluation/ 
17. Specialist Pharmacy Service. A collaborative audit on the quality of medication related 
information provided when transferring patients from secondary care to primary care 
and the subsequent medicines reconciliation in primary care report and tools. Accessed 
on April 2018 via https://www.sps.nhs.uk/articles/a-collaborative-audit-on-the-quality-of-medication-
related-information-provided-when-transferring-patients-from-secondary-care-to-primary-care-and-the-
subsequent-medicines-reconciliation-in-primary-c/ 
18. National Institute for Health and Clinical Excellence (NICE). Clinical Guideline 183: Drug 
allergy: diagnosis and management. 2014. Accessed in April 2018 via 
https://www.nice.org.uk/guidance/cg183  
19. Dodds L. Medicines Use and Safety. Results of a Collaborative Audit of Pharmacy-led 
Medicines Reconciliation (MR) in 56 trusts across E & SE England. 2010. Accessed on 
April 2018 via  https://www.sps.nhs.uk/articles/results-of-a-collaborative-audit-of-
pharmacy-led-medicines-reconciliation-mr-in-56-trusts-across-e-se-england/ 
20. Northern Ireland Regulation and Quality Improvement Authority. Regional Audit of 
Medicines Reconciliation on the Immediate Discharge Document  
https://www.rqia.org.uk/RQIA/files/9d/9da8c378-696e-452a-b2e0-2bed505f53d5.pdf 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
